Dilute Russell's viper venom time (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Dilute Russell's viper venom time" in English language version.

refsWebsite

Global rank English rank

18nih.gov

4^th place

15doi.org

2^nd place

6semanticscholar.org

11^th place

8^th place

3worldcat.org

5^th place

1elsevier.com

610^th place

704^th place

1murdoch.edu.au

6,278^th place

3,907^th place

1handle.net

102^nd place

76^th place

doi.org

Favaloro EJ (4 August 2019). "The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA)". American Journal of Hematology. 94 (11): 1290–1296. doi:10.1002/ajh.25606. PMID 31379004. S2CID 199438687.
Macfarlane RG (July 1967). "Russell's viper venom, 1934-64". British Journal of Haematology. 13 (4): 437–51. doi:10.1111/j.1365-2141.1967.tb00754.x. PMID 6067638. S2CID 2208466.
Marsh NA (July 1998). "Use of snake venom fractions in the coagulation laboratory". Blood Coagulation & Fibrinolysis. 9 (5): 395–404. doi:10.1097/00001721-199807000-00001. PMID 9712287.
Exner T, Rickard KA, Kronenberg H (October 1975). "Studies on phospholipids in the action of a lupus coagulation inhibitor". Pathology. 7 (4): 319–28. doi:10.3109/00313027509081688. PMID 1223721. S2CID 24552164.
Thiagarajan P, Pengo V, Shapiro SS (October 1986). "The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants". Blood. 68 (4): 869–74. doi:10.1182/blood.V68.4.869.869. PMID 3092888.
Exner T, Papadopoulos G, Koutts J (August 1990). "Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'". Blood Coagulation & Fibrinolysis. 1 (3): 259–66. doi:10.1097/00001721-199008000-00002. PMID 2129412.
Castro-Amorim J, Oliveira A, Mukherjee AK, Ramos MJ, Fernandes PA (2023-07-10). "Unraveling the Reaction Mechanism of Russell's Viper Venom Factor X Activator: A Paradigm for the Reactivity of Zinc Metalloproteinases?". Journal of Chemical Information and Modeling. 63 (13): 4056–4069. doi:10.1021/acs.jcim.2c01156. ISSN 1549-9596. PMC 10336966. PMID 37092784.
Hillarp A, Strandberg K, Gustafsson KM, Lindahl TL (August 2020). "Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays". Journal of Thrombosis and Haemostasis. 18 (8): 1866–1873. doi:10.1111/jth.14829. PMID 32294291.
Vandevelde A, Devreese KM (2022-04-13). "Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances". Journal of Clinical Medicine. 11 (8): 2164. doi:10.3390/jcm11082164. ISSN 2077-0383. PMC 9025581. PMID 35456258.
Moore GW (March 2014). "Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants". Seminars in Thrombosis and Hemostasis. 40 (2): 163–171. doi:10.1055/s-0033-1364185. ISSN 0094-6176. PMID 24500573.
Flieder T, Weiser M, Eller T, Dittrich M, von Bargen K, Alban S, Kuhn J, Knabbe C, Birschmann I (May 2018). "Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants". Thrombosis Research. 165: 101–106. doi:10.1016/j.thromres.2018.03.009. PMID 29627719.
Favaloro EJ, Gilmore G, Arunachalam S, Mohammed S, Baker R (August 2019). "Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa" (PDF). Thrombosis Research. 180: 10–19. doi:10.1016/j.thromres.2019.05.013. PMID 31158643. S2CID 174807712.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". Journal of Thrombosis and Haemostasis. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. hdl:11379/21509. PMID 16420554. S2CID 9752817.
Kajy M, Mathew A, Ramappa P (9 October 2019). "Treatment Failures of Direct Oral Anticoagulants". American Journal of Therapeutics. 28 (1): e87–e95. doi:10.1097/MJT.0000000000001083. PMID 31599766. S2CID 204029056.
Kaul M, Erkan D, Sammaritano L, Lockshin MD (July 2007). "Assessment of the 2006 revised antiphospholipid syndrome classification criteria". Ann. Rheum. Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.

elsevier.com

linkinghub.elsevier.com

Hillarp A, Strandberg K, Gustafsson KM, Lindahl TL (August 2020). "Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays". Journal of Thrombosis and Haemostasis. 18 (8): 1866–1873. doi:10.1111/jth.14829. PMID 32294291.

handle.net

hdl.handle.net

Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". Journal of Thrombosis and Haemostasis. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. hdl:11379/21509. PMID 16420554. S2CID 9752817.

murdoch.edu.au

researchrepository.murdoch.edu.au

Favaloro EJ, Gilmore G, Arunachalam S, Mohammed S, Baker R (August 2019). "Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa" (PDF). Thrombosis Research. 180: 10–19. doi:10.1016/j.thromres.2019.05.013. PMID 31158643. S2CID 174807712.

nih.gov

pubmed.ncbi.nlm.nih.gov

Favaloro EJ (4 August 2019). "The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA)". American Journal of Hematology. 94 (11): 1290–1296. doi:10.1002/ajh.25606. PMID 31379004. S2CID 199438687.
Macfarlane RG (July 1967). "Russell's viper venom, 1934-64". British Journal of Haematology. 13 (4): 437–51. doi:10.1111/j.1365-2141.1967.tb00754.x. PMID 6067638. S2CID 2208466.
Marsh NA (July 1998). "Use of snake venom fractions in the coagulation laboratory". Blood Coagulation & Fibrinolysis. 9 (5): 395–404. doi:10.1097/00001721-199807000-00001. PMID 9712287.
Exner T, Rickard KA, Kronenberg H (October 1975). "Studies on phospholipids in the action of a lupus coagulation inhibitor". Pathology. 7 (4): 319–28. doi:10.3109/00313027509081688. PMID 1223721. S2CID 24552164.
Thiagarajan P, Pengo V, Shapiro SS (October 1986). "The use of the dilute Russell viper venom time for the diagnosis of lupus anticoagulants". Blood. 68 (4): 869–74. doi:10.1182/blood.V68.4.869.869. PMID 3092888.
Exner T, Papadopoulos G, Koutts J (August 1990). "Use of a simplified dilute Russell's viper venom time (DRVVT) confirms heterogeneity among 'lupus anticoagulants'". Blood Coagulation & Fibrinolysis. 1 (3): 259–66. doi:10.1097/00001721-199008000-00002. PMID 2129412.
Castro-Amorim J, Oliveira A, Mukherjee AK, Ramos MJ, Fernandes PA (2023-07-10). "Unraveling the Reaction Mechanism of Russell's Viper Venom Factor X Activator: A Paradigm for the Reactivity of Zinc Metalloproteinases?". Journal of Chemical Information and Modeling. 63 (13): 4056–4069. doi:10.1021/acs.jcim.2c01156. ISSN 1549-9596. PMC 10336966. PMID 37092784.
Hillarp A, Strandberg K, Gustafsson KM, Lindahl TL (August 2020). "Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays". Journal of Thrombosis and Haemostasis. 18 (8): 1866–1873. doi:10.1111/jth.14829. PMID 32294291.
Vandevelde A, Devreese KM (2022-04-13). "Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances". Journal of Clinical Medicine. 11 (8): 2164. doi:10.3390/jcm11082164. ISSN 2077-0383. PMC 9025581. PMID 35456258.
Moore GW (March 2014). "Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants". Seminars in Thrombosis and Hemostasis. 40 (2): 163–171. doi:10.1055/s-0033-1364185. ISSN 0094-6176. PMID 24500573.
Flieder T, Weiser M, Eller T, Dittrich M, von Bargen K, Alban S, Kuhn J, Knabbe C, Birschmann I (May 2018). "Interference of DOACs in different DRVVT assays for diagnosis of lupus anticoagulants". Thrombosis Research. 165: 101–106. doi:10.1016/j.thromres.2018.03.009. PMID 29627719.
Favaloro EJ, Gilmore G, Arunachalam S, Mohammed S, Baker R (August 2019). "Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa" (PDF). Thrombosis Research. 180: 10–19. doi:10.1016/j.thromres.2019.05.013. PMID 31158643. S2CID 174807712.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". Journal of Thrombosis and Haemostasis. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. hdl:11379/21509. PMID 16420554. S2CID 9752817.
Kajy M, Mathew A, Ramappa P (9 October 2019). "Treatment Failures of Direct Oral Anticoagulants". American Journal of Therapeutics. 28 (1): e87–e95. doi:10.1097/MJT.0000000000001083. PMID 31599766. S2CID 204029056.
Kaul M, Erkan D, Sammaritano L, Lockshin MD (July 2007). "Assessment of the 2006 revised antiphospholipid syndrome classification criteria". Ann. Rheum. Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.

ncbi.nlm.nih.gov

Castro-Amorim J, Oliveira A, Mukherjee AK, Ramos MJ, Fernandes PA (2023-07-10). "Unraveling the Reaction Mechanism of Russell's Viper Venom Factor X Activator: A Paradigm for the Reactivity of Zinc Metalloproteinases?". Journal of Chemical Information and Modeling. 63 (13): 4056–4069. doi:10.1021/acs.jcim.2c01156. ISSN 1549-9596. PMC 10336966. PMID 37092784.
Vandevelde A, Devreese KM (2022-04-13). "Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances". Journal of Clinical Medicine. 11 (8): 2164. doi:10.3390/jcm11082164. ISSN 2077-0383. PMC 9025581. PMID 35456258.
Kaul M, Erkan D, Sammaritano L, Lockshin MD (July 2007). "Assessment of the 2006 revised antiphospholipid syndrome classification criteria". Ann. Rheum. Dis. 66 (7): 927–30. doi:10.1136/ard.2006.067314. PMC 2497429. PMID 17337473.

semanticscholar.org

api.semanticscholar.org

Favaloro EJ (4 August 2019). "The Russell viper venom time (RVVT) test for investigation of lupus anticoagulant (LA)". American Journal of Hematology. 94 (11): 1290–1296. doi:10.1002/ajh.25606. PMID 31379004. S2CID 199438687.
Macfarlane RG (July 1967). "Russell's viper venom, 1934-64". British Journal of Haematology. 13 (4): 437–51. doi:10.1111/j.1365-2141.1967.tb00754.x. PMID 6067638. S2CID 2208466.
Exner T, Rickard KA, Kronenberg H (October 1975). "Studies on phospholipids in the action of a lupus coagulation inhibitor". Pathology. 7 (4): 319–28. doi:10.3109/00313027509081688. PMID 1223721. S2CID 24552164.
Favaloro EJ, Gilmore G, Arunachalam S, Mohammed S, Baker R (August 2019). "Neutralising rivaroxaban induced interference in laboratory testing for lupus anticoagulant (LA): A comparative study using DOAC Stop and andexanet alfa" (PDF). Thrombosis Research. 180: 10–19. doi:10.1016/j.thromres.2019.05.013. PMID 31158643. S2CID 174807712.
Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, Derksen RH, De Groot PG, et al. (2006). "International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)". Journal of Thrombosis and Haemostasis. 4 (2): 295–306. doi:10.1111/j.1538-7836.2006.01753.x. hdl:11379/21509. PMID 16420554. S2CID 9752817.
Kajy M, Mathew A, Ramappa P (9 October 2019). "Treatment Failures of Direct Oral Anticoagulants". American Journal of Therapeutics. 28 (1): e87–e95. doi:10.1097/MJT.0000000000001083. PMID 31599766. S2CID 204029056.

worldcat.org

Castro-Amorim J, Oliveira A, Mukherjee AK, Ramos MJ, Fernandes PA (2023-07-10). "Unraveling the Reaction Mechanism of Russell's Viper Venom Factor X Activator: A Paradigm for the Reactivity of Zinc Metalloproteinases?". Journal of Chemical Information and Modeling. 63 (13): 4056–4069. doi:10.1021/acs.jcim.2c01156. ISSN 1549-9596. PMC 10336966. PMID 37092784.
Vandevelde A, Devreese KM (2022-04-13). "Laboratory Diagnosis of Antiphospholipid Syndrome: Insights and Hindrances". Journal of Clinical Medicine. 11 (8): 2164. doi:10.3390/jcm11082164. ISSN 2077-0383. PMC 9025581. PMID 35456258.
Moore GW (March 2014). "Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants". Seminars in Thrombosis and Hemostasis. 40 (2): 163–171. doi:10.1055/s-0033-1364185. ISSN 0094-6176. PMID 24500573.